GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / News / EUCAST develops a new reference method for MICs determination in Mycobacterium tuberculosis

EUCAST develops a new reference method for MICs determination in Mycobacterium tuberculosis

8 Setembro, 2020

The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has recently described a new universal reference method for the minimum inhibitory concentration (MIC) determination in Mycobacterium tuberculosis complex (MTBC) isolates – a tool commonly used to assess the efficacy of antimycobacterials in vitro and to detect isolates that acquired resistance during the therapy.

Moreover, this methodology allows the evaluation of the distribution of clinical isolates according to antibacterial activity, which is an essential factor to establish the epidemiological cut off value (ECOFF) – defined as the highest MIC measurement for isolates that have not acquired mechanisms of resistance.

There are several methods used to determine MIC for MTBC isolates, however, the lack of consensus between them have made difficult to establish a methodological standardization and generated several breakpoints per agent, which led the EUCAST subcommittee to the Antimicrobial Susceptibility Testing (AMST) to develop a standard reference method. IHMT-NOVA took part of this multicentric study, in which Professor Miguel Viveiros, deputy director of IHMT-NOVA and a EUCAST AMST subcommittee member, and Diana Machado, from the Medical Microbiology Unit, were the researchers involved.

Commenting on the study, the authors highlighted the importance of this new method for the accurate diagnosis of resistance to antimicrobials in tuberculosis (TB). According to the published report, for now on this method will allow “a rigorous approach in the establishment of clinical breakpoints in MTBC globally”, based on the distribution of MICs, data on pharmacodynamics and pharmacokinetics, and on clinical results as well.

Additionally, it’s emphasized that “resistant TB contributes to about 30% of the annual deaths due to antimicrobial resistance”, mostly resulting from the mortality rate caused by multidrug resistant TB (44%). Consequently, the precision diagnosis will have an impact on the establishment of “the most effective regimen with the least side effects”, and also to “minimize financial costs”, given that the cost associated to resistant TB treatment is 6.6 times higher than the one related to susceptible TB.

Read here the new EUCAST recommendations and learn more about the MTBC clinical breakpoint setting strategy.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

IHMT selected for the pilot phase of the Research Data Repository Service of the FCT

  In order to promote good practices in Open Science with regard to research data and … [Read More...]

Paulo Ferrinho interviewed for the new e-magazine of European and Developing Countries Clinical Trials Partnership (EDCTP)

Paulo Ferrinho, professor and Diretor of Public Global Health Departament at the Instituto de … [Read More...]

How can we improve the environmental performance of our laboratories?

  Every day in NOVA's laboratories research is carried out with the consumption of numerous … [Read More...]

PhD student from GHTM attended the India|EMBO Lecture Course

Ronise Silva, a PhD student under the Tropical Diseases and Global Health program at the Institute … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013